Average Co-Inventor Count = 6.27
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Texas System (23 from 5,444 patents)
2. Chempartner Corporation (6 from 7 patents)
3. Navire Pharma, Inc. (3 from 3 patents)
27 patents:
1. 12286406 - Inhibitors of receptor interacting protein kinase I for the treatment of disease
2. 12186324 - Imidazopiperazine inhibitors of transcription activating proteins
3. 11945815 - PTPN11 inhibitors
4. 11932643 - Substituted heterocyclic inhibitors of PTPN11
5. 11840536 - Heterocyclic inhibitors of PTPN11
6. 11753381 - Inhibitors of receptor interacting protein kinase I for the treatment of disease
7. 11718612 - Inhibitors of receptor interacting protein kinase I for the treatment of disease
8. 11690850 - Inhibitors of receptor interacting protein kinase I for the treatment of disease
9. 11560366 - Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
10. 11466017 - Heterocyclic inhibitors of PTPN11
11. 11434233 - Heterocyclic inhibitors of ATR kinase
12. 11365189 - Heterocyclic inhibitors of tyrosine kinase
13. 11173145 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
14. 11104675 - PTPN11 inhibitors
15. 11058688 - Imidazopiperazine inhibitors of transcription activating proteins